German generic drugmaker Stada (STAGn.DE) said it was holding talks about being taken over with rival suitors Advent International and Cinven Partners.
Stada’s executive board has “started open-minded talks to allow the interested parties to explain their strategic concepts and evaluate further value-enhancing potential with regards to the potential offer price,” it said in a statement on Monday.
READ FULL ARTICLE HERE